The global allergy diagnostics market is expected to reach USD 5.74 Billion by 2022 from USD 3.49 Billion in 2017, at a CAGR of 10.5%. Geographically, the allergy diagnostics market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW).
Access Report at www.rnrmarketresearch.com/contact…ame=249143 .
Asian region is estimated to grow at the fastest rate which can be attributed to the improving life sciences research infrastructure in emerging economies and rising investments by governments to promote research activities.
Key Target Audience for this Report:
- Allergy diagnostics reagents, kits, and instruments manufacturers
- Allergy diagnostics vendors and distributors
- Hospitals
- Diagnostic laboratories
- Allergy diagnostic service providers
- Academic research institutes
- Venture capitalists and investors
- Research institutes and clinical research organizations (CROs)
- Government associations
Allergy diagnostics market is segmented into inhaled allergens, food allergens, drug allergens, and other allergens. In 2017, the inhaled allergens segment is expected to account for the largest share of the allergy diagnostics market.
Increasing environmental pollution is one of the major factors driving the growth of this segment. The assay kits segment is expected to lead the global allergy diagnostics market in 2017.
Access Sample Report at www.rnrmarketresearch.com/contact…ame=249143 .
The global allergy diagnostics market is segmented by product & service, test type, allergen, end user, and region. By product & service, the allergy diagnostics market is segmented into assay kits, instruments, and services.
The widespread availability and large consumption of assay kits in allergy testing are expected to drive the growth of this segment in the coming years.
Premium Insights
1 Allergy Diagnostics: Market Overview
2 Allergy Diagnostics Market, By Allergens (2017)
3 Geographic Snapshot of the Allergy Diagnostics Market
4 Allergy Diagnostics Market, By Test Type, 2017 vs 2022
Access report @ www.rnrmarketresearch.com/contact…ame=249143 .
The key players in the allergy diagnostics market include Thermo Fisher Scientific Inc. (US), Siemens AG (Germany), Danaher Corporation (US),Omega Diagnostics Group PLC (UK), Hitachi Chemical Co., Ltd.
(Japan), bioMérieux SA (France), Stallergenes Greer (UK), HOB Biotech Group Suzhou Co., Ltd. (China), HYCOR Biomedical (US), Lincoln Diagnostics, Inc.
(US), EUROIMMUN AG (Germany), INDOOR Biotechnologies, Inc. (US), DR. FOOKE - Achterrath Laboratorien GmbH (Germany), R-Biopharm AG (Germany), GA Generic Assays GmbH (Germany), Tecan Trading AG (Switzerland), DST Diagnostische Systeme & Technologien GmbH (Germany), ROXALL Medical GmbH (Germany), ALK-Abelló A/S (Denmark), Angsana Molecular & Diagnostics Laboratory Pte Ltd.
(Singapore), Allergy Therapeutics (UK), HAL Allergy Group (Netherlands), Theradiag (France), Allergy Therapeutics (UK), Astra Biotech GmbH (Germany), and Demeditec Diagnostics GmbH (Germany).
Premium Insights
1 Allergy Diagnostics: Market Overview
2 Allergy Diagnostics Market, By Allergens (2017)
3 Geographic Snapshot of the Allergy Diagnostics Market
4 Allergy Diagnostics Market, By Test Type, 2017 vs 2022
The global allergy diagnostics market is segmented by product & service, test type, allergen, end user, and region. The assay kits segment is expected to lead the global allergy diagnostics market in 2017.
News From
RnR Market Research Category: Industry Reports & Market Analysis Profile: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
